OPT 8.54% 44.5¢ opthea limited

Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial, page-5

  1. 4,807 Posts.
    lightbulb Created with Sketch. 390
    next quarter could see more good news if results are positive
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.